Ara
Toplam kayıt 1, listelenen: 1-1
Tocilizumab Treatment In Juvenile Idiopathic Arthritis Patients: A Single Center Experience
(2019)
Tocilizumab is a monoclonal antibody against interleukin-6 that has recently emerged as an alternative treatment modality for juvenile idiopathic arthritis (JIA). In the present study, we aimed to discuss the clinical and ...